chr10-60356289-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.114+33136C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.728 in 152,168 control chromosomes in the GnomAD database, including 40,810 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 40810 hom., cov: 33)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0800

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.892 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020987.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_020987.5
MANE Select
c.114+33136C>T
intron
N/ANP_066267.2
ANK3
NM_001204404.2
c.64-76650C>T
intron
N/ANP_001191333.1
ANK3
NM_001320874.2
c.114+33136C>T
intron
N/ANP_001307803.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000280772.7
TSL:1 MANE Select
c.114+33136C>T
intron
N/AENSP00000280772.1
ANK3
ENST00000373827.6
TSL:1
c.97-76650C>T
intron
N/AENSP00000362933.2
ANK3
ENST00000503366.6
TSL:2
c.64-76650C>T
intron
N/AENSP00000425236.1

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
110652
AN:
152050
Hom.:
40777
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.754
Gnomad AMR
AF:
0.741
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.749
Gnomad SAS
AF:
0.915
Gnomad FIN
AF:
0.748
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.778
Gnomad OTH
AF:
0.745
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.728
AC:
110729
AN:
152168
Hom.:
40810
Cov.:
33
AF XY:
0.734
AC XY:
54619
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.603
AC:
25029
AN:
41496
American (AMR)
AF:
0.742
AC:
11336
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2743
AN:
3468
East Asian (EAS)
AF:
0.748
AC:
3869
AN:
5172
South Asian (SAS)
AF:
0.915
AC:
4423
AN:
4834
European-Finnish (FIN)
AF:
0.748
AC:
7919
AN:
10590
Middle Eastern (MID)
AF:
0.803
AC:
236
AN:
294
European-Non Finnish (NFE)
AF:
0.778
AC:
52910
AN:
68002
Other (OTH)
AF:
0.746
AC:
1576
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1523
3046
4569
6092
7615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.770
Hom.:
26588
Bravo
AF:
0.716
Asia WGS
AF:
0.801
AC:
2785
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.1
DANN
Benign
0.23
PhyloP100
-0.080
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4948410; hg19: chr10-62116047; API